Mental Health & Substance Abuse

Behavioral health, substance-use treatment, and related coverage/programs.

66 events unlock with a free account

18 grant announcements48 rulemakings this week

Create free account →

August 2026

Rulemaking

Comment period closing · Drug Enforcement Administration · Aug 1DEAClosed

Schedules of Controlled Substances: Placement of Tianeptine in Schedule I

Comment period closed · Department of Health and Human Services · Aug 1HHSClosed

OASH Request for Information Temporary Placement of 7-Hydroxymitragynine Above a Specified Threshold in Schedule I

July 2026

Rulemaking

Comment period closing · Department of Health and Human Services · Jul 31HHSClosed

OASH Request for Information Temporary Placement of 7-Hydroxymitragynine Above a Specified Threshold in Schedule I

Comment period closing · Bureau of Alcohol, Tobacco, Firearms, and Explosives · Jul 31ATFClosed

Revising Definitions of Adjudicated as a Mental Defective and Committed to a Mental Institution

Notice · Food and Drug Administration · Jul 31FDA

2026-000193 - Procter and Gamble - Vicks ZZZQuil PureZZZs Stress Support - Calms Mind, Relaxes Body and supports Powerful Sleep

Notice · Food and Drug Administration · Jul 31FDA

2026-000180 - Herb Pharm - Herb Pharm, Kava Liquid Extract (Cinnamon) - Support for mild, occasional anxiety

Notice · Food and Drug Administration · Jul 31FDA

2026-000179 - Herb Pharm - Herb Pharm, Kava Liquid Extract (Ginger Lime) - Support for mild, occasional anxiety

Notice · Food and Drug Administration · Jul 31FDA

2026-000178 - Herb Pharm - Herb Pharm, Kava Liquid Extract (Orange) - Promotes peaceful relaxation, reduces stress and frustration

Notice · Food and Drug Administration · Jul 31FDA

2026-000177 - Herb Pharm - Herb Pharm, Kava Liquid Extract (Orange) - Support for mild, occasional anxiety

Comment period closed · Drug Enforcement Administration · Jul 31DEAClosed

Comment period closing · Drug Enforcement Administration · Jul 30DEAClosed

Comment period closing · Food and Drug Administration · Jul 30FDAClosed

Determination of Regulatory Review Period for Purposes of Patent Extension; COBENFY

Comment period closing · Food and Drug Administration · Jul 30FDAClosed

Determination of Regulatory Review Period for Purposes of Patent Extension; COBENFY

Comment period closing · Food and Drug Administration · Jul 30FDAClosed

Determination of Regulatory Review Period for Purposes of Patent Extension; COBENFY

Legislation

Bill introduced · Jul 30

A bill to prohibit the use of Federal funds for gender transition for minors.

Bill introduced · Jul 30

To amend title XVIII of the Social Security Act to expand access to psychological and behavioral services.

Rulemaking

Comment period closing · Centers for Disease Control and Prevention · Jul 28CDCClosed

Comment period closed · Centers for Disease Control and Prevention · Jul 28CDCClosed

Advancing Violence Epidemiology in Real-Time (AVERT) 2026-10513

Legislation

Bill reported · Jul 28Reported

National Plan for Epilepsy Act

Bill reported · Jul 28Reported

National Plan for Epilepsy Act

Upcoming deadlines

Designation of Phenethyl Halides as List I Chemicals

DEA · Comment closes · Aug 11

Request for Information: Training and Care Delivery Models for Safe Administration of Potential FDA-Approved Psychedelic Therapies in Ambulatory Clinical Settings

HRSA · Comment closes · Aug 14

Reporting of the Essentials for Childhood (EfC): Preventing Adverse Childhood Experiences through Data to Action Program 2026-12275

CDC · Comment closes · Aug 19

Petition for Rulemaking of the National Consumers League, Campaign for Fairer Gambling, the National Council for Problem Gambling, the Public Health Advocacy Institute, and Truth in Advertising, Inc.

FTC · Comment closes · Aug 28

mChoice: Improving PrEP Uptake and Adherence among Minority MSM through Tailored Provider Training and Adherence Assistance in Two High Priority Settings 2026-13561

CDC · Comment closes · Sep 8

1–5 of 6

Browse the document archive